Fanconi Anemia | CHOP Research Institute

New Frontiers, Novel Findings in Fanconi Anemia, Concussion Recovery

Published on

Mar 15, 2024

This week, CHOP announces two new Frontier Programs, and researchers define the origins of hematopoietic failure in Fanconi anemia.

CHOP Physician-Scientist in Search of Cure for Fanconi Anemia

Published on

Oct 15, 2020

in Cornerstone Blog

CHOP Physician-Scientist in Search of Cure for Fanconi Anemia

Peter Kurre, MD, seeks to determine to what extent defects in fetal blood forming cells accelerate the loss of bone marrow function in young patients.

Comprehensive Bone Marrow Failure Center

The Comprehensive Bone Marrow Failure Center brings together physicians and researchers to provide state-of-the-art diagnostics, clinical care, and investigational studies, as well as basic research focused on acquired and inherited bone marrow failure.

Kurre Laboratory

The Kurre Laboratory has a longstanding interest in Fanconi Anemia (FA), a genetic condition with prominent hematologic complications.

Peter Kurre, MD

Dr. Kurre's laboratory has longstanding expertise in Fanconi Anemia (FA), a genetic condition with prominent hematologic complications. With training in transplantation and hematopoietic stem cell biology, he hopes to improve the understanding of the progressive hematopoietic failure in patients with bone marrow failure and FA, broaden diagnostic approaches, and develop next generation therapies.

E-mail:

kurrep [at] chop.edu